Kallikrein hypertension is a rare but progressive clinical condition characterized by elevated blood pressure due to abnormal activity of the kallikrein-kinnin system. This form of hypertension is associated with excess production of kallikreins, which leads to increased formation of kinnins, which play a key role in the regulation of vascular tone and renal function. Changes in this mechanism can be caused by both genetic and acquired factors, making this disease the subject of active research in the fields of cardiology and nephrology. The main manifestations of kallikrein hypertension include persistent elevation of blood pressure, which can lead to various complications, such as cardiovascular disease and target organ damage.
History of the disease and interesting historical facts
Kallikrein hypertension was first described in the scientific literature in the mid-20th century. The main studies related to the identification of the role of the kallikrein-kinnin system in the pathogenesis of hypertension began with the works of scientists such as Ksatsi and Potter in the 1950s. The relevance of this area has increased in recent decades, when molecular biology and genetic methods became available, allowing us to study the mechanisms underlying this type of hypertension. Interestingly, in the 1970s, in a study devoted to the study of kinins, it was noted that the activity of kallikreins in the body can vary significantly in different patients, which emphasizes the individuality of this disease.
Epidemiology
Statistical data on the prevalence of kallikrein hypertension are limited, partly due to the rarity of the disease. Some estimates suggest that its prevalence may be less than 1% of all hypertension cases. However, given the increase in hypertension diagnoses overall, the resulting cases of kallikrein hypertension may remain undetected and underestimated. Each individual study may identify special risk groups, such as patients with hereditary diseases or certain metabolic conditions.
Genetic predisposition to this disease
Scientific studies show that the presence of mutations in genes encoding components of the kallikrein-kinnin system can lead to the development of kallikrein hypertension. Particular attention is paid to the KLK1 and KLK3 genes, which are responsible for the synthesis of kallikreins. Cases have been described where mutations in these genes lead to excessive production of active forms, which in turn causes a violation of the regulation of vascular tone. In addition to genetic factors, cases of kallikrein hypertension have been reported in patients with kidney disease and endocrine disorders, which may also indicate complex interactions between genetic predispositions and external factors.
Risk factors for the development of this disease
Risk factors for the development of kallikrein hypertension are varied and may include both physical and chemical influences. The main risk factors include:
- Heredity: presence of cases of hypertension in the family.
- High levels of salt in the diet: Excess sodium can increase kallikrein activity.
- Sedentary lifestyle: Lack of physical activity can impair blood pressure regulation.
- Obesity: Excess weight is an additional stress factor for the vascular system.
- Chemical pollutants: Some exogenous toxins can affect the functioning of the endocrine system.
Diagnosis of this disease
Diagnosis of kallikrein hypertension can be challenging because symptoms can be similar to those of other forms of hypertension. Common symptoms include:
- Persistent elevation of blood pressure, often resistant to standard antihypertensive therapy.
- Headaches, especially during episodes of hypertension.
- Difficulty breathing and feeling tired during physical activity.
Laboratory tests typically include:
- Plasma and urine kallikrein levels.
- Kidney function tests.
- Hormonal tests.
Radiological investigations may include renal ultrasound and angiography to rule out vascular abnormalities. Differential diagnosis should include other forms of hypertension, such as primary and secondary, including endocrine causes.
Treatment
Treatment of kallikrein hypertension requires a comprehensive approach, including lifestyle changes and drug therapy. General recommendations may include:
- Reduce consumption of salt and fat.
- Increased physical activity and weight loss.
- Regular monitoring of blood pressure.
Pharmacological treatment may include:
- Angiotensin receptor antagonists.
- ACE inhibitors.
- Beta blockers.
Surgical treatment may be considered if renal vascular stenosis or other anatomical abnormalities are detected. Other treatments may include physical therapy and alternative methods.
List of medications used to treat this disease
Key drugs used to treat kallikrein hypertension include:
- Lisinopril (ACE inhibitor).
- Losartan (angiotensin II receptor antagonist).
- Metoprolol (beta blocker).
- Furosemide (diuretic).
- Captopril (ACE inhibitor).
Disease monitoring
Monitoring of patients with kallikrein hypertension includes regular control stages aimed at assessing the progress of the disease and the effectiveness of treatment. The prognosis in this category of patients may vary, but with timely diagnosis and adequate treatment, significant improvement in the condition can be expected. Complications may include:
- Cardiovascular diseases.
- Kidney damage.
- Strokes.
Age-related features of the disease
Kallikrein hypertension can manifest itself differently depending on the age group. In children and adolescents, it may be less noticeable and associated with hereditary factors. In adults, it is often more pronounced, with a greater risk of complications. Older people tend to have more complex forms of the disease due to comorbidities and multiple medications.
Questions and Answers
- What symptoms may indicate kallikrein hypertension? Symptoms may include persistently high blood pressure, headaches, and fatigue with physical activity.
- How is kallikrein hypertension diagnosed? Diagnosis includes tests for kallikrein levels, kidney function tests, and blood pressure measurements.
- What treatment is recommended for kallikrein hypertension? Treatment involves lifestyle changes and antihypertensive medications, and in severe cases may involve surgery.
- What are the main risk factors for the disease? The main factors include heredity, high salt intake, physical inactive lifestyle, obesity and chemical pollution.
- What is the prognosis for patients with kallikrein hypertension? The prognosis depends on the severity of the disease and the adequacy of treatment; if the diagnosis is made in time, the chances of recovery increase significantly.
Advice from Dr. Oleg Korzhikov
As recommendations for patients with kallikrein hypertension, Dr. Oleg Korzhikov emphasizes the importance of:
- Regular monitoring of blood pressure using home tonometers.
- Maintaining a healthy lifestyle with moderate physical activity.
- Limiting salt intake in the diet and avoiding excessive stress.
The doctor also recommends seeking medical attention at the first sign of high blood pressure, as early intervention is key to successful treatment and preventing complications.
